NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO) stock price, news, charts, stock research, profile.
Open | $3.690 |
Close | $3.460 |
Volume / Avg. | 11.485K / 1.307M |
Day Range | 3.460 - 3.690 |
52 Wk Range | 2.889 - 7.599 |
Market Cap | $18.349M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 2.98% |
Days to Cover | 1.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ: NRBO) through any online brokerage.
Other companies in NeuroBo Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was reported by Ladenburg Thalmann on Wednesday, December 7, 2022. The analyst firm set a price target for 6.00 expecting NRBO to rise to within 12 months (a possible 60.43% upside). 0 analyst firms have reported ratings in the last year.
The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $3.74 last updated April 17, 2024 at 9:27 AM EDT.
There are no upcoming dividends for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.